VTRS Long-Term Debt History: $12.48B (FY2025)

Fiscal year	Q1	Q2	Q3	Q4
FY26	$12.4B−12.4%	$11.6B−9.2%	Not reported	Not reported
FY25	$14.2B−11.8%	$12.8B−13.2%	$12.5B−12.7%	$12.5B−11.1%
FY24	$16.1B−11.1%	$14.7B−14.6%	$14.3B−16.2%	$14.0B−13.3%
FY23	$18.1B−3.7%	$17.2B−10.2%	$17.1B−8.8%	$16.2B−10.1%
FY22	$18.8B−15.1%	$19.2B−8.2%	$18.7B−5.7%	$18.0B−8.6%

01—History

Long-Term Debt History

Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.

$12.48B

YoY changeLargest recent move+100.0%in FY20Latest −11.1%

02—Ledger

Long-Term Debt, period by period

Period	Value	Change	Source
FY2025	$12.48B	−11.1%	10-K
FY2024	$14.04B	−13.3%	10-K
FY2023	$16.19B	−10.1%	10-K
FY2022	$18.02B	−8.6%	10-K
FY2021	$19.72B	−12.1%	10-K
FY2020	$22.43B	+100.0%	10-K
FY2019	$11.21B	—	10-K

03—Questions

What is long-term debt?

Long-term debt includes bonds, mortgages, and other borrowings with maturities greater than one year.

What is Viatris's current long-term debt?

Viatris (VTRS) annual long-term debt for 2025 was $12.48B, a 11.10% decline from 2024. Viatris long-term debt for the quarter ending June 30, 2026 was $11.61B.

What was Viatris's long-term debt in 2024?

Viatris annual long-term debt for 2024 was $14.04B, a 13.28% decline from 2023.

What was Viatris's long-term debt in 2023?

Viatris annual long-term debt for 2023 was $16.19B, a 10.14% decline from 2022.

What is Viatris's 5-year long-term debt CAGR?

Viatris long-term debt grew at a compound annual growth rate (CAGR) of 11.06% from FY2020 to FY2025, going from $22.43B to $12.48B over 5 years.

Company: Viatris
Ticker: VTRS
Sector: Healthcare
Industry: Pharmaceutical Preparations

Viatris Long-Term Debt 2019-2026 | VTRS

Key Statistics